Search

everythinglearnresearchcommunity

for

Search:↓

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

Dutasteride and finasteride can help increase hair growth gene expression but need further improvement.

Dutasteride helps slow hair loss and boosts hair growth.

Oral Janus kinase inhibitors are effective for treating alopecia areata in adults.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

About half the patients treated with capecitabine and docetaxel developed severe hand-foot syndrome.

JAK inhibitors show promise for treating various skin diseases.

Finasteride may improve prostate cancer therapy by enhancing testosterone's benefits and reducing risks.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

JAK inhibitors for alopecia areata have different safety risks, requiring specific monitoring for each drug.

The new dutasteride formula can be applied to the skin, may promote hair growth, and has fewer side effects.

Upadacitinib successfully treated a child's severe skin and hair loss issues.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

GTx-024 and Danazol affect the uterus like DHT, while GTx-007 has little impact.

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Bicalutamide may effectively treat female pattern hair loss with minimal side effects.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.